基金双周报：ETF市场跟踪报告 证券分析师 | 陈 | 瑶 | 投资咨询资格编号：S1060524120003 | | --- | --- | --- | | 郭子睿 | | 投资咨询资格编号：S1060520070003 | | 任书康 | | 投资咨询资格编号：S1060525050001 | | 研究助理 | | | | 高 | 越 | 一般从业资格编号：S1060124070014 | | 胡心怡 | | 一般从业资格编号：S1060124030069 | 证券研究报告 2025年6月30日 请务必阅读正文后免责条款 报告摘要 2 ETF市场回顾： • 收益表现与资金流向：近两周ETF产品整体表现较好。主要宽基ETF中，创业板指ETF涨幅最大，行业与主题产品中，金融地产行业ETF涨幅最大。近两周， 主要宽基ETF中，中证A500、中证1000、科创50ETF资金净流入，沪深300ETF资金净流出额最大。科技ETF在年初大幅流出后，自3月起转为资金流入，近两 周资金流入速度有所减缓，医药和金融地产ETF资金由净流出转为净流入，军工ETF资金流入速度放缓。债券ETF方面，受债市反弹影响，信用债ETF资金加 ...

"过去7年的确经历了家电行业的增长驱动力从国内的地产逐渐转变为更新换代，以及全球化增长。从这 个视角出发，未来家电行业的研究也该是全球化的。"孙谦说。 今年以来，据不完全统计，包括东方证券（600958）、财通证券、兴业证券（601377）、中金公司 （601995）、国金证券（600109）、华金证券、开源证券、华安证券（600909）、天风证券、浙商证券 （601878）等在内，已有近30家券商研究所发生分析师"转会"或职位变动。 除了券商研究所首席流动频频，更有团队"组团"跳槽。今年3月，国投证券前固收首席分析师尹睿哲及 其团队已集体加盟国金证券。尹睿哲在中证协登记已变更为国金证券，一同变更登记的还有魏雪、胡依 林、毛庆秋等尹睿哲团队成员。同月，华福证券原首席经济学家燕翔重返方正证券（601901），担任首 席经济学家一职。与之一同回到方正证券的，还有分析师沈重衡、朱成成、许茹纯、金晗等。 【导读】多家券商研究所首席跳槽，卖方人员流动依然频繁 卖方人员流动依然频繁。记者获悉，华创证券传媒互联网联席首席分析师廖志国于近日加盟广发证券 （000776）。中证协官网显示，廖志国2021年加入华创证券研究所，今 ...

ETF Market Overview - The performance of ETFs has been generally positive in the last two weeks, with the exception of the Sci-Tech 100 and Sci-Tech 50 ETFs. The largest gains were seen in ETFs tracking the Hang Seng Index and the CSI 2000, while the manufacturing sector ETFs showed the highest increase among industry and thematic products [3][11]. - In terms of fund flows, major broad-based ETFs experienced significant net inflows, particularly the CSI 300 and the SSE 50 ETFs. After a substantial outflow at the beginning of the year, technology ETFs have shifted to net inflows since March, although the inflow rate has slowed in the last two weeks [3][11]. Fund Flow Analysis - As of April 25, 2025, a total of 15 new ETFs were launched, with a combined issuance of 8.99 billion shares, all of which are stock ETFs. Compared to the end of 2024, the scale of various ETFs has increased, with commodity ETFs, bond ETFs, industry + dividend ETFs, QDII ETFs, and broad-based ETFs rising by 120.33%, 38.17%, 14.44%, 7.58%, and 1.14% respectively [21][22]. - The cumulative fund flow for broad-based ETFs has shown a trend of inflows since early April 2025, particularly for the CSI 300, CSI 1000, and CSI 2000 ETFs, with the CSI 300 ETF seeing a net inflow exceeding 130 billion [12][14]. Thematic ETF Performance - The technology-themed ETFs have shown strong performance, particularly those tracking the new exchange's Southeast Asia Technology Index, with overseas technology ETFs outperforming domestic ones. In terms of fund flows, ETFs tracking the Hang Seng Technology Index have seen significant net inflows, while those tracking 5G communications have experienced outflows [27][28]. - The healthcare-themed ETFs have also performed well, with those tracking innovative drug indices seeing notable gains. However, funds have shifted from inflows to outflows for medical, military, dividend, and consumer ETFs in the last two weeks [16][28]. ETF Product Structure - The structure of newly launched ETFs indicates a growing trend towards thematic and sector-specific investments, with a notable increase in the issuance of stock ETFs. The overall market for ETFs is expanding, reflecting a shift in investor preferences towards diversified and thematic investment strategies [21][22].

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report - In the past two weeks, most ETF products have performed poorly, with only a few exceptions. The capital flow trends of different types of ETFs vary, and the scale of most ETFs has changed to some extent compared to the end of 2024 [2]. 3. Summary by Relevant Catalogs 3.1 ETF Market Review 3.1.1 Main Type ETF Fund Flows Overview - In the past two weeks, most broad - based ETFs had net capital inflows, with the CSI 300 ETF having the largest net inflow. Among them, the products tracking the STAR 50 had the smallest decline among broad - based ETFs, and the military industry ETF had the smallest decline among industry and theme products [9][11]. 3.1.2 Main Type ETF Cumulative Fund Flows - **Broad - based ETFs**: Since 2025, broad - based ETFs have generally seen capital outflows, but recently, due to large - scale capital inflows into the CSI 300 ETF and others, most broad - based ETFs have achieved net capital inflows. In April, except for A - series ETFs, all types of broad - based ETFs have changed from net outflows to net inflows, with significant inflows into the CSI 300, CSI 1000, and CSI 2000 ETFs [12]. - **Industry and Theme ETFs**: Technology ETFs have seen capital inflows since March, and the inflow speed has accelerated in the past two weeks. Pharmaceutical ETFs have changed from outflows to inflows, while financial real - estate ETFs have changed from inflows to outflows. Dividend ETFs have seen continuous small - scale capital inflows this year, and the net inflow speed has slightly increased in the past two weeks [20]. - **Bond ETFs**: Since 2025, credit - bond and treasury - bond ETFs have had net capital inflows, while convertible - bond ETFs have had net outflows. Affected by the bond - market rebound, treasury - bond ETFs have seen accelerated capital inflows since March, but in the past two weeks, treasury - bond and convertible - bond ETFs have changed from net inflows to net outflows, while short - term financing ETFs have had net inflows [20]. 3.1.3 ETF Product Structure Distribution - **Newly - issued Products**: As of April 11, 12 new ETFs were established in the past two weeks, with a total issuance share of 4.439 billion, including 11 stock ETFs and 1 QDII ETF [25]. - **Product Scale**: Compared with the end of 2024, except for broad - based ETFs, the scales of various types of ETFs have increased. The scales of commodity ETFs, bond ETFs, industry + dividend ETFs, and QDII - ETFs have increased by 71.48%, 32.76%, 12.22%, and 2.48% respectively, while the scale of broad - based ETFs has decreased by 1.42% [25]. 3.1.4 Manager Scale Distribution - As of April 11, China Asset Management has the largest on - exchange ETF scale, reaching 67.3518 billion yuan. E Fund's ETF management scale has expanded by more than 25.449 billion yuan compared to a year ago [26]. 3.2 Classification of ETF Tracking 3.2.1 Technology Theme ETF - **Performance**: Products tracking semiconductor - related indexes such as the CSI Semiconductor have performed well in the past two weeks, and overseas technology ETFs have performed worse than domestic ones [32]. - **Fund Flows**: Products tracking Hong Kong technology indexes such as the Hang Seng Tech have had the largest net capital inflows in the past two weeks, while products tracking the CSI All - Share Semiconductor have had net outflows [32]. 3.2.2 Dividend Theme ETF - **Performance**: The ETF product tracking the MSCI China A - Share International Low Volatility (USD) has had the smallest decline in yield in the past two weeks [33]. - **Fund Flows**: Products tracking the Dividend Low Volatility index have had the largest net capital inflows in the past two weeks, while products tracking the Guoxin Hong Kong - Stock Connect Central - SOE Dividend index have had significant net outflows [33]. 3.2.3 Consumption Theme ETF - **Performance**: Products tracking agricultural indexes such as the China Securities Grain Index have performed well in the past two weeks. The S&P 500 Consumer Discretionary Select Index ETF has a high premium [36]. - **Fund Flows**: The ETF tracking the 800 Consumption Index has had the largest net capital inflows in the past two weeks, while products tracking the CSI Wine Index have had net outflows [36]. 3.2.4 Pharmaceutical Theme ETF - **Performance**: Products tracking the STAR Biotech Index have performed well in the past two weeks [39]. - **Fund Flows**: ETFs tracking the Hong Kong Innovative Drug (CNY) and Hong Kong - Stock Connect Innovative Drug indexes have had the largest net capital inflows in the past two weeks, while products tracking the Hang Seng Healthcare Index have had net outflows [39]. 3.2.5 Large - scale Manufacturing Theme ETF - **Performance**: Products tracking utility - related indexes such as the Green Power Index have performed well in the past two weeks [42]. - **Fund Flows**: Products tracking the CSI Military Industry Index have had the largest net capital inflows in the past two weeks, while products tracking new - energy indexes such as the New - Energy Battery Index have had net outflows [42]. 3.2.6 QDII ETF - **Performance**: Products tracking the S&P 500 Consumer Discretionary Select Index have performed well in the past two weeks, and the QDII - ETF tracking this index has a high premium [44]. - **Fund Flows**: Products tracking the Hang Seng Tech Index have had the largest net capital inflows in the past two weeks, while ETF products tracking the Hang Seng Healthcare Index have had net outflows [44]. 3.3 Hot - Topic ETF Tracking 3.3.1 AI Theme ETF - **Performance**: AI - themed products have performed poorly in the past two weeks, with an average yield of - 9.12%. The product tracking the CS Artificial Intelligence index has the highest yield [52]. - **Fund Flows**: Since February 2024, there has been a large - scale net capital inflow. After a significant outflow from September to October 2024, the overall trend has been a rapid inflow. In the past two weeks, the capital inflow speed has slowed down, with a net inflow of 516 million yuan [52]. 3.3.2 Robot Theme ETF - **Performance**: Robot - themed products have performed poorly in the past two weeks, with an average yield of - 9.38%. The product tracking the Automobile Index has the highest yield [56]. - **Fund Flows**: After December 2024, the overall capital flow has shown a rapid inflow trend. In the past two weeks, the capital inflow speed has accelerated, with a net inflow of 1.625 billion yuan [56]. 3.3.3 "National Team" Holding ETF - As of the end of 2024, the "National Team" (only counting Huijin, Guoxin, and Chengtong) held a total of 320.396 billion shares of ETFs. In the past two weeks, there has been a large - scale net capital inflow of 186.118 billion yuan, with a net inflow of 106.611 billion yuan on April 8 alone [2].

Investment Rating - The report indicates a positive outlook for the public fund distribution industry, particularly driven by stock ETFs and bond funds, while active equity funds are experiencing a decline [1][11]. Core Insights - The growth in non-monetary fund distribution in 2024 is primarily driven by stock ETFs, with a notable increase in bond fund distribution, while active equity fund distribution has declined despite market recovery [1][11]. - The distribution landscape shows that banks lead in active equity funds, while brokerages dominate in index funds, with banks catching up in the second half of 2024 [1][11]. - The report emphasizes the need for a balance between investor returns, channel returns, and fund company returns to enhance investor satisfaction and support the long-term development of capital markets [1][11]. Summary by Sections Distribution Scale - As of the end of 2024, the distribution scale for non-monetary funds among banks, brokerages, and third-party institutions reached 42.16 trillion, 19.06 trillion, and 32.66 trillion respectively, reflecting increases of 4.3%, 18.5%, and 5.7% compared to previous periods [11][12]. - The increase in distribution scale is mainly driven by stock index and fixed-income products, with significant growth in stock index fund distribution among banks and brokerages [11][12]. Product Trends - The report notes a shift in the distribution structure, with banks transitioning from a focus on active equity funds to a dominance of fixed-income products, alongside a rapid increase in stock index fund distribution in the second half of 2024 [11][12]. - The distribution of stock index funds among leading banks such as China Merchants Bank, Industrial and Commercial Bank of China, and China Construction Bank saw substantial growth, with increases of 38.9%, 72.4%, and 44.1% respectively [12].

// 深圳楼市新政要点 // 对深圳市住房公积金贷款和利息补贴政策进行了调整优化，包括提高住房公积金贷款额度、降低公积金贷款最低首付款比例、取消异地住房公积金贷款的 户籍和首套房限制等，旨在进一步满足职工的住房需求，更好发挥住房公积金制度的保障作用。 主要要点如下： 一、住房公积金贷款最高额度提高至231万元 1、调整最高（基础）额度。个人申请最高额度从50万元提高至60万元；家庭申请最高额度从90万元提高至110万元。 2、调整最高额度上浮情形和比例。购买本市首套住房上浮比例从20%提高至40%。多子女家庭购房上浮比例从10%提高至50%。该政策适用于有两个及以 上子女的家庭，未成年和成年子女均计算在内。全国范围内有公积金贷款记录的成年子女不计入。新增购买本市保障性住房的上浮情形，上浮比例为 20%。 3、同时符合多种上浮情形可累加上浮比例，最高上浮110%，即个人最高可贷126万元，家庭最高可贷231万元。 二、调整最低首付款比例 1、职工使用住房公积金贷款购买本市首套或第二套住房的，最低首付款比例均为20%；职工使用住房公积金贷款购买本市保障性住房的，最低首付款比 例为15%。 3月16日，深圳市住房公 ...

Investment Rating - The report does not explicitly state an investment rating for the chemical pharmaceutical industry or the specific company being analyzed. Core Insights - The company, Guangshentang, is focused on innovative drug development, particularly in the field of hepatitis B treatment, with its "Dengfeng Plan" showing significant potential for clinical breakthroughs [14][15][16]. - The inclusion of the company's clinical project in the national optimization pilot for innovative drug trials indicates strong recognition from regulatory authorities, which may expedite the drug approval process [14][15]. - The company's research team possesses extensive experience in innovative drug development, which is crucial for the success of the Dengfeng Plan [15][16]. Summary by Sections Company Overview - Guangshentang is transitioning from a generic drug manufacturer to an innovative drug developer, maintaining a strong focus on hepatitis B treatment [15][16]. - The company has established a robust research and development team with significant expertise in the field [15][16]. Clinical Development - The Dengfeng Plan includes a multi-target, all-oral treatment strategy for hepatitis B, combining several innovative components [15][16][20]. - Clinical trials for the drugs GST-HG131 and GST-HG141 are progressing, with GST-HG141 currently in Phase III and GST-HG131 in Phase II [17][18]. Market Position and Strategy - The company aims to address unmet needs in the hepatitis B treatment market, particularly for patients who do not respond well to existing nucleoside therapies [20][21]. - Guangshentang is exploring the integration of AI technology in its drug development processes to enhance efficiency [22]. Financial Outlook - Despite recent losses, the company is focused on increasing revenue and improving gross margins through strategic marketing and cost management [23]. - The company plans to leverage capital markets to support its innovative drug development initiatives [23].